跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Anidulafungin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Anidulafungin
Approved
STANDARD
Anidulafungin
Pharmacia and Upjohn Company LLC
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
fcc360bc70b2d0ae
Company
Pharmacia and Upjohn Company LLC
Type
Standard
Approval Details
Approval Id
fcc360bc70b2d0ae
Drug Approval Philippines Name
Anidulafungin
Product Name
Anidulafungin
Registration Number
DR-XY38322
Brand Name
Anidulafungin
Generic Name
Eraxis
Dosage Form
Lyophilized Powder For Injection (IV Infusion)
Dosage Strength
100 mg
Manufacturer
Pharmacia and Upjohn Company LLC
Importer
Pfizer, Inc.
Company Detail Path
/organization/pharmacia-and-upjohn-company-llc
Importer Detail Path
/organization/pfizer-inc-pleasant-prairie-wisconsin-united-states
Issuance Date
25 June 2020
Expiry Date
03 August 2025
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
fcc360bc70b2d0ae
Type
Standard
Back to Philippines FDA Approvals